tykhr
sign in
free sign up
CytoMed Therapeutics Limited Ordinary Shares
Biotechnology
Healthcare
GDTC
11.54 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.97
52 week high
3.50
high
2.20
52 week low
0.00
low
1.97
growth
32.26 %
previous Close
1.93
P/E ratio
market cap
25.37 M
div yield
0
usd
Mar 2025
qoq
revenue
52.42 K
0.00 %
net incoming
-1.08 M
0.00 %
eps
0.00 %
-200.00 %
eps surprise
-200.00 %
net profit margin
-2055.08 %
-2055.00 %
operating incoming
-1.23 M
0.00 %
net change in cash
0.00 %
cash on hand
3.44 M
0.00 %
cost of revenue
52.42 K
0.00 %
top